and Cardiovascular Disease: A Story in Evolution.
作者信息
Bajaj Archna, Susztak Katalin, Damrauer Scott M
机构信息
From the Division of General Internal Medicine, Department of Medicine (A.B.), Renal Electrolyte and Hypertension Division, Department of Medicine (K.S.), Department of Genetics (K.S.), Division of Vascular Surgery, Department of Surgery (S.M.D.), University of Pennsylvania, Philadelphia; and Department of Surgery, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA (S.M.D.).
From the Division of General Internal Medicine, Department of Medicine (A.B.), Renal Electrolyte and Hypertension Division, Department of Medicine (K.S.), Department of Genetics (K.S.), Division of Vascular Surgery, Department of Surgery (S.M.D.), University of Pennsylvania, Philadelphia; and Department of Surgery, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA (S.M.D.)
出版信息
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1587-1589. doi: 10.1161/ATVBAHA.117.309756.
Abstract
摘要
相似文献
1
and Cardiovascular Disease: A Story in Evolution.与心血管疾病：一个不断演变的故事。
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1587-1589. doi: 10.1161/ATVBAHA.117.309756.
2
Sends Its REGARDS to Cardiovascular Disease.向心血管疾病致以问候。
Circ Genom Precis Med. 2018 Jun;11(6):e002212. doi: 10.1161/CIRCGEN.118.002212.
3
Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).风险变异与心血管疾病：非裔美国人肾脏疾病与高血压研究（AASK）的结果
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.
4
APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.载脂蛋白L1基因型、肾脏与心血管疾病以及老年人死亡情况
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.
5
The Apolipoprotein L1 Gene and Cardiovascular Disease.载脂蛋白L1基因与心血管疾病
Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4 Suppl):2-5. doi: 10.14797/mdcj-12-4s1-2.
6
Apolipoproteins and Blood Pressure: A Story of Evolution in Biomarker Analysis.载脂蛋白与血压：生物标志物分析的演变历程
J Am Coll Cardiol. 2017 Mar 28;69(12):1575-1576. doi: 10.1016/j.jacc.2017.02.005.
7
Apolipoprotein L1 and Kidney Disease in African Americans.载脂蛋白L1与非裔美国人的肾脏疾病
Trends Endocrinol Metab. 2016 Apr;27(4):204-215. doi: 10.1016/j.tem.2016.02.002. Epub 2016 Mar 3.
8
APOL1 risk variants, race, and progression of chronic kidney disease.APOL1 风险变异体、种族与慢性肾脏病的进展。
N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.
9
APOL1 and Mortality in Patients on Dialysis.载脂蛋白L1与透析患者的死亡率
Cardiorenal Med. 2019;9(4):261-264. doi: 10.1159/000501303. Epub 2019 Jun 11.
10
APOL1 and kidney disease.APOL1 与肾脏疾病。
Curr Opin Nephrol Hypertens. 2012 Mar;21(2):179-82. doi: 10.1097/MNH.0b013e32835012ab.
引用本文的文献
1
Management of traditional risk factors for the development and progression of chronic kidney disease.慢性肾脏病发生和进展的传统危险因素的管理。
Clin Kidney J. 2023 Apr 26;16(11):1737-1750. doi: 10.1093/ckj/sfad101. eCollection 2023 Nov.
2
C1QL1/CTRP14 Is Largely Dispensable for Atherosclerosis Formation in Apolipoprotein-E-Deficient Mice.C1QL1/CTRP14对载脂蛋白E缺乏小鼠的动脉粥样硬化形成基本无影响。
J Cardiovasc Dev Dis. 2022 Oct 6;9(10):341. doi: 10.3390/jcdd9100341.
3
Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.反义寡核苷酸可改善足细胞特异性 APOL1 风险变异小鼠的肾功能障碍。
Mol Ther. 2022 Jul 6;30(7):2491-2504. doi: 10.1016/j.ymthe.2022.04.007. Epub 2022 Apr 20.
4
APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis.非洲遗传血统个体中的 APOL1 风险变异导致内皮细胞缺陷，从而加重败血症。
Immunity. 2021 Nov 9;54(11):2632-2649.e6. doi: 10.1016/j.immuni.2021.10.004. Epub 2021 Oct 12.
5
Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.烟酸增加他汀类药物治疗患者高密度脂蛋白中的致动脉粥样硬化蛋白。
Arterioscler Thromb Vasc Biol. 2021 Aug;41(8):2330-2341. doi: 10.1161/ATVBAHA.121.316278. Epub 2021 Jun 17.
6
Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations.评估沙特阿拉伯人群中已知的与慢性肾病相关的基因变异。
BMC Nephrol. 2018 Apr 17;19(1):88. doi: 10.1186/s12882-018-0890-9.
本文引用的文献
1
Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).风险变异与心血管疾病：非裔美国人肾脏疾病与高血压研究（AASK）的结果
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.
2
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.足细胞中人类APOL1风险变异体的转基因表达可诱发小鼠肾病。
Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.
3
Race, APOL1 Risk, and eGFR Decline in the General Population.普通人群中的种族、载脂蛋白L1风险与估算肾小球滤过率下降
J Am Soc Nephrol. 2016 Sep;27(9):2842-50. doi: 10.1681/ASN.2015070763. Epub 2016 Mar 10.
4
APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.载脂蛋白L1基因型、肾脏与心血管疾病以及老年人死亡情况
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.
5
Million Veteran Program: A mega-biobank to study genetic influences on health and disease.百万退伍军人计划：一个大型生物银行，用于研究遗传对健康和疾病的影响。
J Clin Epidemiol. 2016 Feb;70:214-23. doi: 10.1016/j.jclinepi.2015.09.016. Epub 2015 Oct 9.
6
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.APOL1风险变异与南非黑人的HIV相关性肾病密切相关。
J Am Soc Nephrol. 2015 Nov;26(11):2882-90. doi: 10.1681/ASN.2014050469. Epub 2015 Mar 18.
7
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
8
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.在收缩压干预试验中，载脂蛋白L1基因变异与普遍存在的肾脏疾病相关，但与普遍存在的心血管疾病无关。
Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.
9
Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.携带 APOL1 基因突变的个体心血管疾病负担增加。
Circ Res. 2014 Feb 28;114(5):845-50. doi: 10.1161/CIRCRESAHA.114.302347. Epub 2013 Dec 30.
10
APOL1 risk variants, race, and progression of chronic kidney disease.APOL1 风险变异体、种族与慢性肾脏病的进展。
N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.
Zotero 插件